Peregrine Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-184,695
| Closed | -$7.54M | – | 328 |
|
|
2023
Q1 | $7.54M | Buy |
184,695
+5,521
| +3% | +$225K | 0.22% | 205 |
|
|
2022
Q4 | $6.92M | Buy |
179,174
+28,712
| +19% | +$1.11M | 0.22% | 213 |
|
|
2022
Q3 | $8M | Buy |
150,462
+19,342
| +15% | +$1.03M | 0.26% | 182 |
|
|
2022
Q2 | $7.64M | Sell |
131,120
-109
| -0.1% | -$6.35K | 0.23% | 196 |
|
|
2022
Q1 | $10M | Sell |
131,229
-43,782
| -25% | -$3.34M | 0.24% | 178 |
|
|
2021
Q4 | $10.5M | Buy |
175,011
+20,071
| +13% | +$1.21M | 0.21% | 190 |
|
|
2021
Q3 | $8.68M | Sell |
154,940
-30,435
| -16% | -$1.7M | 0.18% | 224 |
|
|
2021
Q2 | $11.2M | Sell |
185,375
-8,250
| -4% | -$501K | 0.2% | 224 |
|
|
2021
Q1 | $13.6M | Sell |
193,625
-27,097
| -12% | -$1.9M | 0.25% | 202 |
|
|
2020
Q4 | $13.2M | Sell |
220,722
-19,974
| -8% | -$1.2M | 0.25% | 189 |
|
|
2020
Q3 | $14.5M | Sell |
240,696
-52,202
| -18% | -$3.14M | 0.38% | 99 |
|
|
2020
Q2 | $15.4M | Sell |
292,898
-42,621
| -13% | -$2.24M | 0.44% | 92 |
|
|
2020
Q1 | $11.3M | Buy |
335,519
+457
| +0.1% | +$15.3K | 0.4% | 107 |
|
|
2019
Q4 | $15.2M | Sell |
335,062
-3,902
| -1% | -$177K | 0.39% | 115 |
|
|
2019
Q3 | $12.9M | Buy |
338,964
+40,203
| +13% | +$1.53M | 0.35% | 124 |
|
|
2019
Q2 | $13M | Buy |
298,761
+56,733
| +23% | +$2.47M | 0.32% | 133 |
|
|
2019
Q1 | $9.21M | Buy |
242,028
+40,889
| +20% | +$1.56M | 0.23% | 161 |
|
|
2018
Q4 | $8.65M | Sell |
201,139
-23,608
| -11% | -$1.02M | 0.24% | 150 |
|
|
2018
Q3 | $11M | Sell |
224,747
-45,826
| -17% | -$2.25M | 0.26% | 150 |
|
|
2018
Q2 | $8.67M | Sell |
270,573
-55,483
| -17% | -$1.78M | 0.22% | 149 |
|
|
2018
Q1 | $10.2M | Sell |
326,056
-40,547
| -11% | -$1.26M | 0.25% | 146 |
|
|
2017
Q4 | $16.7M | Sell |
366,603
-37,538
| -9% | -$1.71M | 0.39% | 105 |
|
|
2017
Q3 | $15.2M | Buy |
404,141
+48,859
| +14% | +$1.83M | 0.36% | 111 |
|
|
2017
Q2 | $16.9M | Sell |
355,282
-1,014
| -0.3% | -$48.4K | 0.42% | 87 |
|
|
2017
Q1 | $17M | Sell |
356,296
-11,873
| -3% | -$565K | 0.43% | 86 |
|
|
2016
Q4 | $11.9M | Buy |
368,169
+6,239
| +2% | +$202K | 0.31% | 130 |
|
|
2016
Q3 | $12.4M | Buy |
+361,930
| New | +$12.4M | 0.32% | 129 |
|